Screener
Intellia Therapeutics NTLA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's debt-to-equity?
- Intellia Therapeutics (NTLA) reported debt-to-equity of 0.1× in Q2 2026.
- What is the long-term trend for Intellia Therapeutics's debt-to-equity?
- Over 5 years (2020 to 2025), Intellia Therapeutics's debt-to-equity has grown at a 13.3% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Intellia Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude